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Abstract
Background:  Disorders of coagulation have long been associated with inflammatory bowel
disease. Children, as well as adults, with both active and inactive ulcerative colitis have been found
to have abnormal coagulation and fibrinolysis. Disseminated intravascular coagulation arises from
an overwhelming of the haemostatic regulatory mechanisms leading to an excessive generation of
thrombin and a failure of the normal inhibitory pathways to prevent systemic effects of this enzyme.
Ulcerative colitis has been associated with disseminated intravascular coagulation in conjunction
with septicemia, toxic megacolon and surgery.
Case presentation: A fourteen-year-old boy with a history of poorly controlled ulcerative colitis
presented with nonbilious emesis, hematochezia, and hematuria. Laboratory workup revealed
disseminated intravascular coagulation. He was placed on triple antibiotics therapy. An infectious
workup came back negative. A computerized tomography (CT) scan of the abdomen revealed a
marked thickening and irregularity of the bladder wall as well as wall thickening of the rectosigmoid,
ascending, transverse, and descending colon. Patient's clinical status remained stable despite a
worsening of laboratory values associated with disseminated intravascular coagulation. Patient was
begun on high dose intravenous steroids with improvement of the disseminated intravascular
coagulation laboratory values within 12 hours and resolution of disseminated intravascular
coagulopathy within 4 days. A thorough infectious workup revealed no other causes to his
disseminated intravascular coagulation.
Conclusions: The spectrum of hypercoagulable states associated with ulcerative colitis varies
from mild to severe. Although disseminated intravascular coagulation associated with ulcerative
colitis is usually related to septicemia, toxic megacolon or surgery, we present a case of an
ulcerative colitis flare resulting in disseminated intravascular coagulation and a bladder hematoma.
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Background
A wide variety of disorders are associated with the devel-
opment of disseminated intravascular coagulation (DIC).
Initiation usually involves mechanical tissue injury and or
endothelial cell activation and injury. DIC arises from an
overwhelming of the haemostatic regulatory mechanisms
leading to an excessive generation of thrombin and a fail-
ure of the normal inhibitory pathways to prevent systemic
effects of the enzyme leading to DIC [1]. Ulcerative colitis
has been associated with DIC. In previously reported
cases, DIC has arisen from active disease in conjunction
with septicemia, toxic megacolon or surgery [2-5]. The
authors report a pediatric case of DIC associated with a
colitis flare resulting in a bladder hematoma.
Case presentation
A 14-year-old boy with a diagnosis of ulcerative colitis
based on colonic histology, serology and a normal barium
study of his small bowels was admitted with a five-day
history of nonbilious vomiting and bloody diarrhea.
Additional symptoms included recent onset hematuria,
and low-grade fevers to 100.4 C over the prior four days.
He had also sustained a 25 lb weight loss in the last six
months, indicating a lack of disease control.
As an outpatient, his maintenance therapy included
mesalamine (1 gram three times a day), and mercaptopu-
rine (75 mg once per day). In addition, he had been
started on prednisone approximately 7 weeks prior for
treatment of an ulcerative colitis flare. His current dose of
prednisone was 10 mg once a day. Soon after symptoms
begun, he had been placed on ciprofloxacin as treatment
for a presumptive flare.
Physical exam showed he was afebrile, with a heart rate of
130 beats per minute, respiratory 16 breaths per minute
and blood pressure 115/67 mmHg. He was alert although
with a sallow appearance. Abdominal exam revealed a
soft nontender nondistended abdomen. Rectal showed
normal external exam with grossly bloody stool. Initial
blood work showed hemoglobin of 12.3, a normal white
blood cell count, normal differential and normal platelet
count with a mildly elevated prothrombin time of 16.2
with an international normalized ratio (INR) of 1.2. Urine
analysis showed a specific gravity of 1.035, 3+blood,
+ketones and > 100 RBC per high powered field and 0–5
WBC per high power field. Abdominal ultrasound
revealed irregular shaped bladder wall.
Patient was placed on intravenous fluids (IV) as well as
metronidazole (IV). Blood and urine cultures were sent
for analysis. Stool was sent for culture and for Clostridium
difficile toxin analysis.
Serial repeat lab works the following day revealed a drop-
ping hemoglobin (7.4 g/dL) and platelet count (64 K/
mm3) increasing PT/PTT (21.3/47 seconds) with an INR
of 1.8. Blood smear showed moderate amount of ellipto-
cytes, schistocytes, microcytes and fragmented red blood
cells. Initial DIC panel revealed an elevated D-dimer of
4.9 mcg/mL with a normal thrombin time and fibrinogen.
Thrombin time subsequently increased to > 120 seconds.
D-dimers increased to 10.3 mcg/mL. A computerized
tomography (CT) scan of the abdomen revealed a marked
thickening and irregularity of the bladder wall as well as
wall thickening of the rectosigmoid, ascending, trans-
verse, and descending colon (Figure 1). Urology was con-
sulted and felt that this represented a submucosal
hematoma.
Patient was begun on broad-spectrum antibiotics because
of concerns regarding possible bacteremia and a worsen-
ing DIC laboratory picture. Blood, stool and urine cul-
tures returned negative. Viral cultures and monoclonal
antibody staining for adenovirus detection in the urine
was negative. Despite a worsening in the DIC panel, the
patient remained clinically unchanged. IV steroids were
begun approximately 36 hours into patient's hospital stay.
Patient had a stabilization of PT/PTT/INR/thrombin time
and D-dimer, and a subsequent normalization of labs
over the following 4-day period ( Figure 2, 3, 4, 5, 6, 7, 8
). Patient's diarrhea and hematuria resolved as well.
Colonscopy revealed chronic colitis consistent with ulcer-
ative colitis. Cystoscopy revealed a fibrin clot consistent
Abdominal CT revealing a marked thickening and irregularity  of the bladder wall consistent with bladder hematoma Figure 1
Abdominal CT revealing a marked thickening and irregularity 
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with submucosal hematoma. Patient was discharged from
the hospital on a steroid taper, and remains in remission
to date.
Conclusions
Disorders of coagulation have long been associated with
inflammatory bowel disease [6-11]. Children, as well as
adults, with both active and inactive ulcerative colitis have
been found to have abnormal coagulation and fibrinoly-
sis[11]. It is unclear whether this is a direct or indirect
result of inflammatory bowel disease.
Although hypocoagulable states have been noted in the
literature, most studies indicate an associated hypercoag-
ulable state. There appears to be an increase in thrombin-
anti-thrombin complex and a decrease in antithrombin III
activity, which causes an increase in thrombin genera-
tion[10,12,13]. Other studies have demonstrated an
increase in fibrinogen content, increase Factor VIII, and
Factor IX activity, platelet count and aggregation
rate[9,12]. These hypercoagulable abnormalities return
towards normal with therapy in direct correlation with
sedimentation rate and clinical disease activity [12], but
can still show mild abnormalities despite clinical
remission[14].
Graphic illustration of C-reactive protein throughout hospi- talization: Day 1 (admission date) – Day 9 (day of discharge) Figure 2
Graphic illustration of C-reactive protein throughout hospi-
talization: Day 1 (admission date) – Day 9 (day of discharge). 
Patient received intravenous steroids at approximately 36 
hours into hospitalization.
Graphic illustration of hemoglobin throughout hospitaliza- tion: Day 1 (admission date) – Day 9 (day of discharge) Figure 3
Graphic illustration of hemoglobin throughout hospitaliza-
tion: Day 1 (admission date) – Day 9 (day of discharge). 
Patient received intravenous steroids at approximately 36 
hours into hospitalization.
Graphic illustration of platelets throughout hospitalization:  Day 1 (admission date) – Day 9 (day of discharge) Figure 4
Graphic illustration of platelets throughout hospitalization: 
Day 1 (admission date) – Day 9 (day of discharge). Patient 
received intravenous steroids at approximately 36 hours into 
hospitalization.
Graphic illustration of prothrombin time throughout hospi- talization: Day 1 (admission date) – Day 9 (day of discharge) Figure 5
Graphic illustration of prothrombin time throughout hospi-
talization: Day 1 (admission date) – Day 9 (day of discharge). 
Patient received intravenous steroids at approximately 36 
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The hypercoagulable state in ulcerative colitis is associated
thromboembolic events; although uncommon, deep vein
thrombosis, pulmonary embolisms and stroke have been
associated with ulcerative colitis[6,15-18]. Disseminated
intravascular coagulopathy is a rare occurrence in inflam-
matory bowel disease. When it occurs, it is usually associ-
ated with other co-founding problems such as septicemia,
toxic megacolon or surgery.
Presented is a case of DIC associated solely with an ulcer-
ative colitis flare resulting in a bladder hematoma. We
presume that the occurrence of DIC in this patient
resulted from an acute flare on top of a chronic unremit-
ting course of ulcerative colitis. A thorough infectious
work-up of this patient did not reveal any infectious etiol-
ogy that would have predisposed him to develop DIC. The
presumed cause of the DIC was damage to the endothelial
wall of the colonic blood vessels, which exposed blood to
excessive amounts of tissue factor. This in turn led to the
excessive generation of thrombin and a failure of the nor-
mal coagulation inhibitory pathways. By treating the
ulcerative colitis flare, we decreased the intestinal inflam-
mation and thereby decreased the endothelial cell dam-
age. This, theoretically, resolved the DIC. Patient's clinical
symptoms and laboratory values normalized after treat-
ment with intravenous steroids, completely resolving the
disseminated intravascular coagulopathy.
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